Propagenix Inc., a Gaithersburg-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine, Friday was acquired by STEMCELL Technologies, Canada’s ...

Genetics and other factors that can determine if a woman is at risk for a recurrence of breast cancer have been identified by researchers at the Georgetown Lombardi Comprehensive Cancer Center. The ...

WASHINGTON (Dec. 15, 2016) -- For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the ...

WASHINGTON -- The mechanistic understanding of the relatively new technique for growing cells in culture indefinitely - known as conditional reprogramming - has been deciphered and reported in the ...